Tesla 's November registrations in France and Denmark halved from a year ago, as the EV maker struggled to reverse market share losses in Europe despite the launch of a new range of its best-selling M... ...

Billionaire Elon Musk has doubled down on his ambition of putting solar-powered AI datacenter satellites in orbit.Convergence Between CompaniesSpeaking to Indian entrepreneur Nikhil Kamath in a podcast appearance on Sunday, Musk shared that there was an increasing "convergence" between Tesla Inc. (NASDAQ:TSLA) , SpaceX and xAI.Musk shared that solar-powered AI satellites in deep space were crucial to "harness a non-trivial amount of the energy of the sun." He added that the future "needs to be" solar-powere ...

Tzido/iStock via Getty Images "Those who sow in tears will reap with sounds of joy." - Psalm 126. Rabbi Ari S. Lorge. Central Synagogue. New York City. October 2, 2025. Yom Kippur. 5786. Rabbi Ari S. Lorge at New York City's Central Synagogue observed there are more than 150 psalms in the Jewish Bible. Those ancient poems, according to the Rabbi's always thought-provoking commentary, can provide guidance to individuals under virtually all circumstances. Sitting in Central Synagogue's congregation on the ...

Cybersecurity can be the next AI gold mineSemiconductor stocks like Nvidia, Broadcom, and Advanced Micro Devices have produced tremendous long-term returns due to their artificial intelligence (AI) chips.While semiconductors are the early winners, the next trillion-dollar AI opportunity may be in cybersecurity. It's always been a hot sector due to cloud platforms and websites needing protection. However, AI can unlock a gold mine for cybersecurity stocks that results in long-term outperformance.Hackers are ...

Core Viewpoint - Tesla's stock is nearing its all-time closing record, with a significant rise in market capitalization, but faces challenges due to high valuation and mixed financial results [1][2][5]. Financial Performance - Tesla reported Q3 2025 revenue of $28.1 billion, exceeding analyst expectations of $26.37 billion, but adjusted earnings per share were $0.50, below the anticipated $0.54 [2]. - The company's gross margin decreased to 18% from 19.8% year-over-year, indicating pressure on profitability [3]. - Net income fell by 37% year-over-year to $1.4 billion, while revenue growth was only 12% and core automotive revenue increased by just 6% [6]. Valuation Concerns - Tesla's price-to-earnings (P/E) ratio exceeds 300, significantly higher than the S&P 500 average of 26, raising concerns about its valuation [5]. - Analysts suggest a potential correction of at least 15% based on a consensus price target of $381, indicating the stock may be overvalued [8]. Competitive Landscape - Increased competition, particularly from Chinese automakers, is putting pressure on Tesla's margins and growth prospects [3][6]. - The company is attempting to launch more modestly priced vehicles to counter competition, but this strategy may not effectively improve profitability [3]. Speculative Nature - The stock's price movements appear to be driven by speculation rather than financial performance, leading to unpredictability in its future trajectory [9]. - Despite the high valuation and declining earnings, Tesla's popularity among retail investors could still drive the stock higher [9].

Tesla Inc. (NASDAQ:TSLA) is hiring silicon module process engineers across all chip manufacturing disciplines in Austin and Palo Alto, according to a post on X by Tesla Yoda.The roles cover processes related to lithography, etching, deposition, epitaxy, metals, implants, polishing, metrology, and inspection.Earlier this week, Tesla CEO Elon Musk announced that candidates with exceptional skills in AI and semiconductor engineering should email at AI_Chips@Tesla.com.Custom AI Chip ProductionAccording to Tesla ...

Core Insights - CRISPR Therapeutics has begun generating revenue from its first product, a blood disorder treatment called Casgevy, which has been approved by regulators [7][10] - Cathie Wood, CEO of Ark Invest, has been consistently increasing her holdings in CRISPR Therapeutics, indicating strong confidence in the company's future growth potential [5][6] - The stock has experienced significant declines, dropping 17% since the approval of Casgevy and over 55% in the past five years, presenting a potential buying opportunity for growth investors [12][13] Company Overview - CRISPR Therapeutics specializes in gene editing technology, which has shown promise in correcting faulty genes responsible for diseases [8] - The company has a market capitalization of $5 billion and its stock is currently priced at $53.47 [11] - CRISPR Therapeutics has a gross margin of -36522.94%, indicating challenges in profitability [11] Product and Revenue Generation - The approval of Casgevy is a significant milestone, demonstrating the effectiveness of CRISPR's technology and paving the way for future product approvals [7][8] - Vertex Pharmaceuticals, a partner of CRISPR, expects Casgevy to generate over $100 million in revenue this year, with CRISPR receiving 40% of the profits [10] - The rollout of gene editing treatments is complex and time-consuming, which means revenue generation will take time [10] Clinical Trials and Future Prospects - CRISPR Therapeutics is advancing other candidates through clinical trials, including CTX310, which has shown positive results in lowering triglycerides and LDL levels [11] - The company is exploring applications of its technology in various fields, including oncology and cardiovascular health [11] - Despite recent stock price declines, the approval of Casgevy and positive trial results suggest that CRISPR Therapeutics has significant growth potential ahead [12][13]

Some analysts are bullish on Tesla's self-driving vehicles gamble, but investors should take a wait-and-see approach.While many automotive companies are trying to figure out how to transition to electric vehicles (EVs), Tesla (TSLA +0.82%) is in the midst of figuring out how to pivot to robotics and autonomous vehicles (AVs). CEO Elon Musk has made this shift a priority, and even part of his potential $1 trillion pay package rests on whether he delivers on some AV goals.There is no guarantee Tesla can pull ...

Core Viewpoint - Tesla stock has experienced significant volatility over the past five years, with substantial price increases and decreases impacting investor returns Group 1: Recent Performance - Investors who purchased Tesla shares a year ago have seen a 25% increase, outperforming the S&P 500's 14.5% return during the same period [2] - However, for much of the year, these investors faced a 37% decline from November 2024 prices, largely due to the negative impact of CEO Elon Musk's political activities on public perception [3] Group 2: Historical Performance - A three-year investment in Tesla from November 25, 2022, would yield a total return of 131%, significantly higher than the market's 75.5% return, despite experiencing a 40% drop in share price before the end of 2022 [6] - For investors who bought shares two years earlier, during the COVID-19 pandemic on November 25, 2020, the five-year performance is nearly identical to the three-year performance, with returns of 131% versus 122% [7] - The market's five-year returns are 21 percentage points better, with an increase of almost 101%, indicating that Tesla has spent more time underperforming compared to the market over the last three years [8] Group 3: Long-Term Investment Perspective - Holding investments for a longer duration increases the likelihood of achieving market-beating returns, as evidenced by Tesla's five-year returns of 122% compared to a staggering 1,790% return over six years, far surpassing the S&P 500's 137% return [10]

Core Points - Elon Musk has been awarded a $1 trillion pay package, marking a first in global corporate history, which was approved by Tesla shareholders [1] - The pay package is designed to motivate Musk's performance with high targets for remuneration, but critics highlight potential loopholes that could allow him to benefit without fully meeting the goals [2][6] - The compensation plan includes 12 tiered grants of restricted stock, with market cap triggers starting at $2 trillion and operational milestones including sales targets and Ebitda tiers [3][4] Compensation Structure - Musk has a ten-year window to achieve the necessary targets to unlock the grants, receiving 35.312 million shares if he meets any one of the operational targets [4] - The operational milestones include sales targets for key products and Ebitda tiers starting at $50 billion and maxing at $400 billion [3] - Critics argue that the lower targets may be too easy to achieve, while the higher goals may be overly ambitious [4] Market Reaction and Implications - Despite criticism, Musk and some Wall Street analysts are optimistic about the pay package, citing a similar arrangement from 2018 that significantly boosted Tesla's share price [5] - The potential for Musk to profit without fully achieving the set targets raises questions about the fairness of the pay package and its implications for Tesla shareholders [6] - The coming years will determine whether this pay package will benefit or harm Tesla and its shareholders [6]